Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gabriel Steg

Showing results (41-50 of 242) with videos related to

Pageof 25
Sort By:
Journal of the American College of Cardiology|October 28, 2017
Lesion Complexity and Outcomes of Extended Dual Antiplatelet Therapy After Percutaneous Coronary InterventionRobert W Yeh, Dean J Kereiakes, P Gabriel Steg, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|November 30, 2014
Clinical presentation and management of stable coronary artery disease: insights from the international prospective CLARIFY registry - results from the Greek national cohortEftihia Sbarouni, Vassilis Voudris, Panagiota Georgiadou, et al.
The American Journal of Cardiology|October 7, 2011
Comparison of acute coronary syndrome in patients receiving versus not receiving chronic dialysis (from the Global Registry of Acute Coronary Events [GRACE] Registry)Hitinder S Gurm, Joel M Gore, Frederick A Anderson, et al.
European Journal of Heart Failure|April 14, 2012
Management and outcomes following an acute coronary event in patients with chronic heart failure 1999-2007Isuru Ranasinghe, Chris Naoum, Bernadette Aliprandi-Costa, et al.
The New England Journal of Medicine|December 25, 2008
Genetic determinants of response to clopidogrel and cardiovascular eventsTabassome Simon, Céline Verstuyft, Murielle Mary-Krause, et al.
The American Journal of Cardiology|July 19, 2015
Balancing Long-Term Risks of Ischemic and Bleeding Complications After Percutaneous Coronary Intervention With Drug-Eluting StentsAlexis Matteau, Robert W Yeh, Edoardo Camenzind, et al.
Cerebrovascular Diseases (Basel, Switzerland)|August 31, 2011
Two-year vascular event rates in patients with symptomatic cerebrovascular disease: the REACH registryNarayanaswamy Venketasubramanian, Joachim Röther, Deepak L Bhatt, et al.
Heart (British Cardiac Society)|September 2, 2011
Risk of ST versus non-ST elevation myocardial infarction associated with non-steroidal anti-inflammatory drugsLamiae Grimaldi-Bensouda, Michel Rossignol, Nicolas Danchin, et al.
JACC. Cardiovascular Interventions|May 6, 2017
Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy StudyEric A Secemsky, Robert W Yeh, Dean J Kereiakes, et al.
Stroke|November 22, 2008
The Essen stroke risk score predicts recurrent cardiovascular events: a validation within the REduction of Atherothrombosis for Continued Health (REACH) registryChristian Weimar, Hans-Christoph Diener, Mark J Alberts, et al.
Pageof 25

Showing results (41-50 of 242) with videos related to

Sort By:
Pageof 25
Journal of the American College of Cardiology|October 28, 2017
Lesion Complexity and Outcomes of Extended Dual Antiplatelet Therapy After Percutaneous Coronary InterventionRobert W Yeh, Dean J Kereiakes, P Gabriel Steg, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|November 30, 2014
Clinical presentation and management of stable coronary artery disease: insights from the international prospective CLARIFY registry - results from the Greek national cohortEftihia Sbarouni, Vassilis Voudris, Panagiota Georgiadou, et al.
The American Journal of Cardiology|October 7, 2011
Comparison of acute coronary syndrome in patients receiving versus not receiving chronic dialysis (from the Global Registry of Acute Coronary Events [GRACE] Registry)Hitinder S Gurm, Joel M Gore, Frederick A Anderson, et al.
European Journal of Heart Failure|April 14, 2012
Management and outcomes following an acute coronary event in patients with chronic heart failure 1999-2007Isuru Ranasinghe, Chris Naoum, Bernadette Aliprandi-Costa, et al.
The New England Journal of Medicine|December 25, 2008
Genetic determinants of response to clopidogrel and cardiovascular eventsTabassome Simon, Céline Verstuyft, Murielle Mary-Krause, et al.
The American Journal of Cardiology|July 19, 2015
Balancing Long-Term Risks of Ischemic and Bleeding Complications After Percutaneous Coronary Intervention With Drug-Eluting StentsAlexis Matteau, Robert W Yeh, Edoardo Camenzind, et al.
Cerebrovascular Diseases (Basel, Switzerland)|August 31, 2011
Two-year vascular event rates in patients with symptomatic cerebrovascular disease: the REACH registryNarayanaswamy Venketasubramanian, Joachim Röther, Deepak L Bhatt, et al.
Heart (British Cardiac Society)|September 2, 2011
Risk of ST versus non-ST elevation myocardial infarction associated with non-steroidal anti-inflammatory drugsLamiae Grimaldi-Bensouda, Michel Rossignol, Nicolas Danchin, et al.
JACC. Cardiovascular Interventions|May 6, 2017
Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy StudyEric A Secemsky, Robert W Yeh, Dean J Kereiakes, et al.
Stroke|November 22, 2008
The Essen stroke risk score predicts recurrent cardiovascular events: a validation within the REduction of Atherothrombosis for Continued Health (REACH) registryChristian Weimar, Hans-Christoph Diener, Mark J Alberts, et al.
Pageof 25